Hydrix Limited (AU:HYD)
ASX:HYD
Want to see AU:HYD full AI Analyst Report?
HYD Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume100.00K
Average Volume (3M)316.59K
Market Cap
AU$7.64M
Enterprise ValueAU$11.49M
Total Cash (Recent Filing)AU$584.18K
Total Debt (Recent Filing)AU$10.33M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding1,909,382,000
10 Day Avg. Volume341,547
30 Day Avg. Volume316,588
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.55
Price to Sales (P/S)0.33
P/FCF Ratio-6.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$22.21M
Bulls Say, Bears Say
Bulls Say
Specialized Medtech Engineering & Regulatory ServicesHydrix’s core business is high-value engineering and regulatory services for medical devices. These capabilities create durable client stickiness across long device development cycles, support recurring regulatory/maintenance revenue, and raise barriers to entry versus generalist engineering firms.
Stronger Gross Margin And Much Smaller Net Loss In 2025The 2025 improvement in gross margin and a materially smaller net loss suggests improving unit economics and operating leverage. If sustained, higher gross margins can fund fixed costs and reduce reliance on external capital, supporting a transition toward consistent profitability.
Sharply Improved Cash Burn And Positive FCF Growth In 2025A sharp reduction in cash burn and strongly positive FCF growth in 2025 indicate tightened working-capital and spending controls. Improved cash generation enhances runway, reduces near-term financing pressure, and provides a clearer path to self-funding if the trend continues.
Bears Say
Consistent Operating Losses And Negative Operating Cash FlowPersistent operating losses and negative operating cash flow across years signal the business is not yet self-sustaining. Continued negative cash generation forces reliance on external capital, constrains reinvestment in growth, and raises the risk of dilution or restructurings.
Negative Shareholder Equity And Weakened Balance SheetNegative shareholder equity and a materially weakened balance sheet elevate solvency risk and limit financial flexibility. With equity below zero, leverage is effectively stressed, making new debt or equity raises more costly and constraining the company’s ability to fund growth or withstand shocks.
Revenue Down Two Consecutive Years; Volatile Top LineTwo years of declining and volatile revenue undermine scale benefits and make margin improvements harder to sustain. A shrinking top line increases pressure on fixed-cost absorption, raises customer concentration and contract renewal risks, and slows durable margin recovery.
Hydrix Limited News
HYD FAQ
What was Hydrix Limited’s price range in the past 12 months?
Hydrix Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Hydrix Limited’s market cap?
Hydrix Limited’s market cap is AU$7.64M.
When is Hydrix Limited’s upcoming earnings report date?
Hydrix Limited’s upcoming earnings report date is Sep 01, 2026 which is in 82 days.
How were Hydrix Limited’s earnings last quarter?
Hydrix Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Hydrix Limited overvalued?
According to Wall Street analysts Hydrix Limited’s price is currently Overvalued.
Does Hydrix Limited pay dividends?
Hydrix Limited does not currently pay dividends.
What is Hydrix Limited’s EPS estimate?
Hydrix Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hydrix Limited have?
Hydrix Limited has 1,909,382,000 shares outstanding.
What happened to Hydrix Limited’s price movement after its last earnings report?
Hydrix Limited reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Hydrix Limited?
Currently, no hedge funds are holding shares in AU:HYD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hydrix Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HYD Sentiment 80%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.66%
12-Months-Change
Fundamentals
Return on Equity
61.09%
Trailing 12-Months
Asset Growth
-27.26%
Trailing 12-Months
Company Description
Hydrix Limited
Hydrix Limited, established in Mulgrave, Australia, in 1993, is a global provider of product design, engineering, and regulatory compliance solutions. The company extends its reach across Australia, Singapore, Europe, and North America, structuring its operations into two distinct divisions: Hydrix Services and Hydrix Medical. The Hydrix Medical division is particularly focused on innovative cardiovascular technology. This includes "The GUARDIAN," an advanced device for cardiac monitoring and alerts aimed at improving quality of life; the "Phyzhon PHYRARI FFR-Wire," which empowers cardiologists to seamlessly integrate diagnostic assessments with therapeutic procedures like stent placement; and "LUDO," a versatile, pre-configured platform offering essential resources for developing Mechanical Circulatory Support (MCS) pumps. Beyond these specialized medical offerings, Hydrix offers comprehensive services covering the entire product development lifecycle, expert consultation on regulatory and clinical matters, and strategic technology commercialization. Its extensive client base spans numerous industries, including medical, consumer, industrial, utilities, defense, aerospace, and mining sectors. The company adopted its current name, Hydrix Limited, in November 2018, having previously operated as Panorama Synergy Limited.
Technical Analysis
X2M Connect Limited
―
dorsaVi Limited
―
Beam Communications Holdings Limited
―
Simble Solutions Ltd.
―
Knosys Ltd.
―